LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)

Objective: to assess the long-term safety and efficiency of tocilizumab (TCZ) therapy in patients with early rheumatoid arthritis (RA) of moderate and high activity, who have completed the basic WA19926 study, as well as the rate of sustained drug-free remission.Subjects and methods. A long-term ope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: E. L. Nasonov, M. L. Stanislav, V. I. Mazurov, T. M. Chernykh, V. N. Sorotskaya, T. S. Salnikova, R. S. Saikovsky, O. V. Reshet’ko, T. A. Popova, E. I. Shmidt, V. P. Tyurin, N. P. Shilkina, I. N. Bokarev, M. Z. Kanevskaya, S. S. Yakushin
Formato: Artigo
Idioma:Russo
Publicado em: IMA-PRESS LLC 2018-07-01
Colecção:Научно-практическая ревматология
Assuntos:
disease-modifying antirheumatic drugs
early rheumatoid arthritis
remission
interleukin 6
tocilizumab
Acesso em linha:https://rsp.mediar-press.net/rsp/article/view/2560
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados